v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets    
Fixed maturity securities available-for-sale, at fair value (amortized cost of $6,012,143 and $5,876,502 as of June 30, 2025, and December 31, 2024, respectively) $ 5,896,818 $ 5,624,773
Short-term investments, at fair value 3,001 3,367
Total investments 5,899,819 5,628,140
Cash and cash equivalents 612,967 599,432
Accrued investment income 53,259 49,595
Deferred acquisition costs 22,910 23,771
Premiums receivable 44,091 53,031
Other assets 107,882 102,549
Deferred tax asset 32,545 65,013
Total assets 6,773,473 6,521,531
Liabilities:    
Loss reserves 551,940 524,715
Unearned premiums 101,205 114,680
Other liabilities 153,447 142,990
Long-term borrowings 743,753 743,050
Total liabilities 1,550,345 1,525,435
Equity:    
Common stock ($0.01 par value; 600,000 shares authorized; 148,385 shares issued and outstanding as of June 30, 2025, and 152,318 shares issued and outstanding as of December 31, 2024) 1,484 1,523
Additional paid-in capital 1,927,372 2,076,788
Accumulated other comprehensive income (104,342) (207,455)
Retained earnings 3,398,614 3,125,240
Total equity 5,223,128 4,996,096
Total liabilities and equity $ 6,773,473 $ 6,521,531